Evidence map›Paper›PMID 26859239›Full record

Observational studyVaccine2016

Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.

Ekaterina Moroz, Randy A Albrecht, Brandon Aden, Ann Bordwine Beeder, Jianda Yuan, Adolfo García-Sastre, Brian R Edlin, Mirella Salvatore

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Effect of Opioid Use on Immune Activation and HIV Persistence on ART.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ekaterina MorozDepartment of Medicine, Weill Cornell Medical College, US.
Randy A AlbrechtDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, US; Global Health and Emerging Pathogens Institute, Icahn School of Medicine Mount Sinai, US.
Brandon AdenDepartment of Medicine, Weill Cornell Medical College, US.
Ann Bordwine BeederDepartment of Medicine, Weill Cornell Medical College, US.
Jianda YuanImmune Monitoring Facility, Ludwig Center for Center Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, US.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, US; Global Health and Emerging Pathogens Institute, Icahn School of Medicine Mount Sinai, US; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, US.
Brian R EdlinDepartment of Medicine, Weill Cornell Medical College, US; Institute for Infectious Disease Research, National Development and Research Institutes, New York, NY, US.
Mirella SalvatoreDepartment of Medicine, Weill Cornell Medical College, US. Electronic address: mis2053@med.cornell.edu.
Cornell University · USIcahn School of Medicine at Mount Sinai · USMemorial Sloan Kettering Cancer Center · USNational Development and Research Institutes · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
HCV Transmission among Young IDUs in NYCR01DA021550 · NIDA · SUNY DOWNSTATE MEDICAL CENTER · PI EDLIN, BRIAN R. · 2008 to 2012
$4.1M
Acute HCV Infection in Injection Drug UsersR01DA016159 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI EDLIN, BRIAN R. · 2004 to 2008
$3.5M
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV PreventionR01DA029512 · NIDA · SUNY DOWNSTATE MEDICAL CENTER · PI EDLIN, BRIAN R. · 2010 to 2014
$3.4M
NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1TR00457NCI NIH HHS P30 CA008748NCRR NIH HHS UL1 RR024996NIAID NIH HHS HHSN272201400008CNIDA NIH HHS R01 DA016159NIDA NIH HHS R01 DA021550NIDA NIH HHS R01 DA029512PHS HHS HHSN272201400008C
6 · The paper itself

Abstract

backgroundInfluenza vaccination is recommended for vulnerable individuals, including active drug users, to prevent influenza complications and decrease influenza spread. Recent studies suggest that opioids negatively regulate immune responses in experimental models, but the extent to which opioid use will affect the humoral responses to influenza vaccine in humans is unknown. This information is critical in maximizing vaccination efforts.

objectiveTo determine whether there is a difference in antibody response after influenza vaccination in heroin or methadone users compared to control subjects.

methodsWe studied active heroin users, subjects on methadone maintenance treatment (MMT) and subjects that did not use any drugs before and 1 and 4 weeks after vaccination with trivalent influenza vaccine (TIV). We measured hemagglutination inhibition and microneutralization titers, and we compared geometric mean titers (GMT), and rates of seroprotection and seroconversion for each of the vaccine strains among the 3 groups of subjects.

resultsHeroin users, subjects on MMT and non-user controls mount a similarly robust serologic response to TIV. GMT and rates of seroprotection and seroconversion were not significantly different among groups.

conclusionOur results suggest that opioid use do not significantly alter antibody responses to influenza vaccine supporting the vaccination effort in these populations.

Indexed as

AdultAntibodies, ViralCase-Control StudiesFemaleHemagglutination Inhibition TestsHeroin DependenceHumansImmunity, HumoralInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza VaccinesMaleMethadoneNeutralization TestsOpiate Substitution TreatmentAntibodies, ViralInfluenza VaccinesMethadoneVaccines, InactivatedHemagglutination inhibitionHeroinInfluenza vaccinationMethadoneMicroneutralizationOpioid users

Identifiers

PMID26859239
PMCPMC4780674
OpenAlexW2259066450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.